180 Life Sciences Corp. (NASDAQ: ATNF), an American biotech company, has seen its stock price soar by 90% on Wednesday after the purchase of a platform that uses blockchain technology.
The company has made a strategic shift to focus on the industry of online gaming.
180 Life Sciences will be able to launch a B2C (business-to consumer) online casino with the intention of expanding into a B2B (business-to business) environment.
The company has positioned itself to be a global provider of technology solutions for gaming operators.
ATNF’s stock had reached nearly $16 by the morning after the announcement. It was only $1.18 the day before.
ATNF enters the Online Gaming Market
180 Life Sciences plans to launch the first online casino by early 2025 if its fundraising efforts and commercialization are successful.
The initial focus of the company is on international markets with high growth, such as India, Brazil and Germany.
The company stated in a release that it believes its recently acquired Gaming Technology Platform combined with an experienced management team, and Nasdaq listings, give it a position of uniqueness as a consolidator within the gaming industry.
The iGaming market, which is set to grow at a rate of $97 billion by 2024 and the segment that uses cryptography will be growing faster than the rest.
This move represents a major opportunity for a firm like 180 Life Sciences. However, Wall Street analysts continue to ignore the company.
180 Life Sciences: Can it sustain its recent stock price rally?
Investors should be cautious despite the recent surge.
It has been announced that the company’s B2C casino will place a priority on operational efficiency and transparent.
In a press release, it stated that the company will use games provided by third parties to improve its customer interface.
This announcement was made shortly after 180 Life Sciences gained compliance with Nasdaq’s listing requirements, and completed a separation deal with Sir Marc Feldmann. The agreement included the issuance of over 57,000 share as part.
The stock is expected to maintain its momentum despite the massive spike in ATNF stock prices. Over 80 million shares were traded versus the usual 64,000 daily.
180 Life Sciences is not offering dividends at this time, which makes it less appealing to investors who are looking for income.
The rapid increase in the stock price may be temporary if there are challenges with the online gaming strategy.
This article This biotech stock surged by a staggering 900% on Wednesday – here’s the reason appeared first on ICD
This site is for entertainment only. Click here to read more
